Vertex Pharmaceuticals (VRTX) Cash from Operations Growth (1y) (2010 - 2026)
Vertex Pharmaceuticals (VRTX) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | 60.84% |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | 85.14% |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | -15.72% |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | 74.39% |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.55 Bn | 54.80 Bn | 3.31 Bn | 3.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.39% |
| Dec 31, 2025 | -14.81% |
| Sep 30, 2025 | -9.37% |
| Jun 30, 2025 | 128.59% |
| Mar 31, 2025 | -37.33% |
| Dec 31, 2024 | 149.19% |
| Sep 30, 2024 | 7.99% |
| Jun 30, 2024 | -430.89% |
| Mar 31, 2024 | 45.19% |
| Dec 31, 2023 | -78.25% |
| Sep 30, 2023 | 32.75% |
| Jun 30, 2023 | -0.47% |
| Mar 31, 2023 | -5.89% |
| Dec 31, 2022 | 8.38% |
| Sep 30, 2022 | 3.05% |
| Jun 30, 2022 | 670.76% |
| Mar 31, 2022 | 3.82% |
| Dec 31, 2021 | 102.43% |
| Sep 30, 2021 | 2.14% |
| Jun 30, 2021 | -119.23% |